Statin Lipid-Lowering Therapy for Acute Myocardial Infarction and Unstable Angina: Efficacy and Mechanism of Benefit
- 31 October 2002
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 77 (10), 1085-1092
- https://doi.org/10.4065/77.10.1085
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase InhibitorsArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Cholesterol LoweringCirculation, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Antiatherothrombotic Properties of StatinsJAMA, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-pointsCurrent Opinion in Lipidology, 1996
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Statins do more than just lower cholesterolThe Lancet, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995